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INTRODUCTION
In acute respiratory distress syndrome, a disturbance of
surfactant synthesis and function leads to an increased surface
tension at the alveolar air-liquid interface. This increased sur-
face tension leads to end-expiratory alveolar collapse, atelec-
tasis, right-to-left shunt, and finally results in hypoxemia (1).
The therapies to counterbalance the increased tendency for
collapse may reverse above vicious sequence.
Partial liquid ventilation (PLV) is one of those therapies.
PLV is performed by conventional gas ventilation of the per-
fluorocarbon-filled lung. Because of its high density and low
surface tension, perfluorocarbon recruits the atelectatic lung
region. A number of animal studies reported an improvement
in gas exchange with this technique (2-9).
Inhaled nitric oxide (NO) is another therapeutic approach
to reduce hypoxemia by selective vasodilation of the pulmonary
vasculature of ventilated lung regions and resultant improve-
ment in ventilation/perfusion matching (10). Administration
of inhaled NO in adult patients with the acute respiratory
distress syndrome has been shown to improve oxygenation
by reducing pulmonary right-to-left shunt (10-12). Although
the response to inhaled NO therapy is quite variable, and even
doubtful especially in patients with severe lung injury (13,
14), it has been suggested that strategies to enhance alveolar
recruitment may augment the responsiveness to inhaled NO
therapy (15).
We did the present study to evaluate the effect of the addi-
tion of low-dose NO gas inhalation to PLV on hemodynamics,
pulmonary function and gas exchange in newborn piglets with
saline lavage-induced acute lung injury. We tested the hypoth-
esis that the addition of low-dose NO gas inhalation to PLV,
a novel modality to enhance alveolar recruitment, has a cumu-
lative effects on oxygenation in acute lung injury.
MATERIALS AND METHODS
Animal Preparations and Surgical Procedures
The institutional Animal Care and Use Committee of the
Samsung Biomedical Research Center, Seoul, Korea approved
this investigation.
Studies were performed on 18, 7-9 day-old newborn piglets
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Combined Effect of Low-dose Nitric Oxide Gas Inhalation with Partial
Liquid Ventilation on Hemodynamics, Pulmonary Function, and Gas
Exchange in Acute Lung Injury of Newborn Piglets
We conducted a randomized animal study to determine whether there is a cumu-
lative effect on hemodynamics, pulmonary function, and gas exchange when low-
dose nitric oxide (NO) is added to partial liquid ventilation (PLV) in acute lung injury.
Eighteen newborn piglets were saline-lavaged repeatedly, and randomly divided
into two groups: PLV with perfluorocarbon group (n=8) and lavage only (control)
group (n=10). Perfluorodecalin (30 mL/kg) was instilled into the endotracheal tube
for 30 min, followed by 5-10 mL/kg/hr. Fifteen minutes after the completion of per-
fluorodecalin dosing, NO (10 ppm) was added to the inspiratory gas in an ‘‘on/off’’
manner. Perfluorodecalin instillation produced a significant improvement in gas
exchange, pulmonary mechanics, shunt, and pulmonary arterial pressure (PAP).
The addition of NO produced a further significant improvement in PaO2 and PAP.
The ‘‘on/off’’ response to NO was seen apparently in PAP, PaO2, dynamic com-
pliance, and shunt. All the variables in control group were remained at near the
after-lavage levels without significant improvements until the end of the experi-
ment. We concluded that NO might have a cumulative effect on gas exchange
when combined with PLV, and this might be attributable to deceased PAP and
V/Q mismatching.
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of mixed strain (Yorkshire, conventional breed, purchased from
Paju farm, Paju, Kyungki-Do, Korea). Surgical preparation
of neonatal piglets was initiated by sedation with ketamine
(20 mg/kg, intramuscular [IM]) and xylazine (2 mg/kg, IM),
followed by thiopental anesthesia (5 mg/kg,  intravenous [IV]).
After local injection with lidocaine (1%), a tracheostomy was
performed, and the piglet was paralyzed with the initial injec-
tion of pancuronium (0.1 mg/kg, IV), followed by hourly
intravenous injections. Sedation was maintained with hourly
doses of thiopental. The paralyzed piglet was placed on a me-
chanical ventilator (Sechrist Infant Ventilator, IV-100 V, Se-
christ Industries, Anaheim, CA, U.S.A.) to attain an arterial
O2 tension of 80-100 mmHg and an arterial CO2 tension of
35-45 mmHg. The right femoral artery was cannulated for
arterial blood gas sampling and systemic arterial blood pres-
sure monitoring. The right femoral vein was cannulated for
administration of fluids and medications. A No. 5 Fr Swan-
Ganz catheter (Baxter Health-care Corp., Irvine, CA, U.S.A.)
was inserted into the right external jugular vein and was ad-
vanced into the pulmonary artery using direct-pressure and
pressure wave monitoring. It was used for sampling of mixed
venous blood and for the measurements of pulmonary artery
and pulmonary arterial wedge pressures. An infusion of 0.9%
saline containing 1U of heparin/mL was provided at 1-2 mL/hr
through the arterial catheter and pulmonary arterial catheter,
both of which were attached to a blood pressure transducer.
A Hewlett Packard neonatal monitoring system (Hewlett-
Packard Model M1276A, Andover, MA, U.S.A.) continu-
ously monitored electrocardiogram, oxygen saturation, and
systemic arterial and pulmonary arterial pressure. Animals
were maintained supine with the head of the bed elevated 20
degrees throughout the study. Constant body temperature
was maintained between 38-39℃using a warmed operating
table and servo-controlled overhead heater.
Perfluorodecalin
Perfluorodecalin (Fluka, Switzerland), a kind of perfluoro-
carbon, is insoluble in water, and is too stable at room temper-
ature to react with air or water, and has the following charac-
teristics; density, 1.95 g/mL at 25℃; kinematic viscosity, 2.9
centistokes at 25℃; boiling point, 142℃; vapor pressure, 14
mmHg at 37℃; surface tension, 15 dyne/cm at 25℃; O2
solubility, 49 mL of gas/100 mL of liquid at 25℃; and CO2
solubility, 140 mL of gas/100 mL of liquid at 37℃.
Nitric Oxide Delivery System
Nitric oxide (NO) was obtained as 800 ppm in nitrogen
in 47-liter stainless steel cylinder that was authenticated and
supplied by Korea Industrial Gases Co. The concentration of
nitrogen dioxide was less than 1%, and the range of error in
the concentration of nitric oxide was within the range of 1%.
NO was decompressed by using a tri-staged regulator and a
rotameter that were designed and assembled by medical engi-
neering team of our hospital, and was injected into the inspi-
ratory limb of mechanical ventilator through a teflon tube.
The injection site of NO was between humidifier and the con-
necting site to endotracheal tube, and was made by using a
part of NO delivery system by Drager Co. The distance be-
tween the site of the NO injection and the connecting site to
endotracheal tube was over 50 cm. The concentration of
NO and NO2 in the inspiratory limb of the ventilatory cir-
cuit just before the entry to the endotracheal tube were mon-
itored by portable electrochemical analyzer (Drager Co.). The
adjustment of NO concentration was done by manipulation
of the regulator and the rotameter. The exhaled gas was elim-
inated by the scavenging system installed at the exhalation
outlet of mechanical ventilator. The flow rate of mechanical
ventilator was maintained over 10 L/min to reduce the reten-
tion time of NO in ventilatory circuit, and thus to diminish
the conversion of NO into NO2 and N2O4.
Experiment Protocols
After a period of stabilization at about 30 min after anesthet-
ic and surgical procedures, the ventilator settings were adjusted
as follows: FiO2 1.0, rate 25/min, PIP 30 cmH2O, PEEP 4
cmH2O, and iT 0.7 sec. These adjusted settings were main-
tained until the end of the experiment. At this point (BASE),
baseline measurements of arterial blood gases, hemodynamic
variables, and pulmonary mechanics were done. Thereafter,
induction of acute lung injury was done by repetitive lung
lavage with warm saline. A dose of 30 mL/kg of 37℃ saline
was instilled into trachea and was removed repeatedly 5-10
times until an arterial O2 tension of 60 mmHg was reached
at the ventilator settings of FiO2 1.0, rate 25/min, PIP 30
cmH2O, PEEP 4 cmH2O, and iT 0.7 sec. Lavage baseline
point, when stabilization was reached, was appointed as after
about an hour after lung lavage. Second measurement of arte-
rial blood gases, hemodynamic variables, and pulmonary me-
chanics were done at this point (LAVAGE). Then, newborn
piglets were randomly divided into two groups: partial liquid
ventilation with perfluorocarbon administration group (PFC+
NO group, n=8) and lavage only group (control group, n=10).
Newborn piglets in PFC+NO group received perfluorode-
calin. An hour after lung lavage, a dose of 30 mL/kg of per-
fluorodecalin was instilled continuously via the side-port of
an adapter that connects ventilator circuit with endotracheal
tube for 30 min. Supplemental instillation of perfluorodecalin
was done once in every one hour with a dose of 5-10 mL/kg
after checking arterial blood gases. Positional change was not
done during and after perfluorodecalin instillation. Fifteen
minutes after the completion of PFC dosing, NO in a concen-
tration of 10 ppm was added to the inspiratory gas in an ‘on/
off’ manner: on for 75 min (first NO on); off for an hour (first
NO off ); on again for an hour (second NO on); and finally off
for an hour until the end of the experiment (second NO off ).Partial Liquid Ventilation and Inhaled Nitric Oxide 815
The control animals were kept being mechanically ventilated
without any interventions during a 5 hr-protocol. Following
measurements of arterial blood gases, hemodynamic variables,
and pulmonary mechanics were done at the end of PFC dos-
ing period (PFC), at 15 min after the beginning of first NO
on (NO), at the end of the first NO on (ON 1), at the beginning
of second NO on (OFF 1), at the end of second NO on (ON
2), and finally at the end of second NO off (OFF 2) in both
groups (Fig. 1).
Measurements of Hemodynamic Variables, Gas
Exchange, Pulmonary Mechanics, and Intrapulmonary
Right-to-Left Shunt
Heart rate (HR), mean arterial pressure (MAP, in mmHg),
and mean pulmonary arterial pressure (MPAP, in mmHg)
were measured by using femoral arterial and pulmonary arte-
rial catheter. Arterial blood pH, PaO2, and PaCO2 were mea-
sured from arterial blood samples taken from the femoral arte-
rial catheter, and were analyzed by using Ciba-Corning blood
gas analyzer. Dynamic compliance, tidal volume, airway resis-
tance, and minute ventilation were measured continuously
by Bicore CP-100R. Intrapulmonary right-to-left shunt was
calculated by Fick equation (Ca-Cc/Cv-Cc). CcO2, CaO2, and
CvO2 are the oxygen content in pulmonary capillary blood,
in arterial blood and in mixed venous blood. Alveolar capillary
O2 content (CcO2) was calculated by using PAO2 (partial pres-
sure of oxygen in the alveoli) from the alveolar gas equation
with PAO2=[(BP-47)×(FiO2)]-PaO2.
Data Analysis and Statistics
All numerical values measured were described as mean±
standard deviation. Arterial blood gases, hemodynamic vari-
ables, pulmonary mechanics, and intrapulmonary shunt were
assessed by repeated measures analysis of variance with the
group as the main effect and time as the within-subject factor
for the analysis of group-by-time interaction and intragroup
differences, taking the Bonferroni principles into account.
Intergroup difference at each time point was evaluated by one-
way analysis of variance. Intragroup comparions with the pre-
vious value were analyzed with paired t-test. We used SPSS
(version 10.0) and StatView (version 5.0) for these analyses.
p-value lower than 0.05 was regarded significant.
RESULTS
Changes in Hemodynamic Variables
Heart rate (HR) showed a significant increase from 148±
16/min to 189±32/min (p<0.05) in PFC+NO group, and
from 131±16/min to 179±39/min (p<0.01) in control
group after lavage. Thereafter, there were no significant ch-
anges in HR in control group. In PFC+NO group, HR de-
monstrated a tendency to decrease during NO on periods, and
to increase during NO off periods. Only the latter was statis-
tically significant (p<0.05). There were no significant differ-
ences in HR over time between both groups (Fig. 2).
Mean arterial pressure (MAP) did not show a significant
change over time in control group. In PFC+NO group, MAP
increased significantly from 65±11 mmHg to 81±15
mmHg after lavage (p<0.01), and decreased significantly
from 84±23 mmHg to 75±26 mmHg during second NO
on period (p<0.05). Intergroup comparison did not demon-
strate significant differences between both groups (Fig. 2).
Pulmonary arterial pressure (PAP) showed a significant
increase from 13±1 mmHg to 36±6 mmHg (p<0.01) in
PFC+NO group, and from 14±1 mmHg to 28±3 mmHg
(p<0.01) in control group after lavage. Thereafter, there were
-1.5 hr
Lavage
Measurement
BASE
Control group Lavage only (n=10)
PFC+NO group Lavage+PFC+NO ‘‘on/off’’ (n=8)
Surgery
LAVAGE PFC NO ON 1 ON 2 OFF 1 OFF 2
PFC iNO (10 ppm) iNO
Second NO
off
Second NO
on
First NO
on
First NO
off
Stabilization
-1 hr 0 hr 30 min 45 min 1 hr 2 hr 3 hr 4 hr 5 hr
Fig. 1. Experimental protocol. PFC, perfluorocarbon; iNO, inhaled nitric oxide.816 C.W. Choi, J.H. Hwang, Y.S. Chang, et al.
no significant alterations in PAP in control group until the
end of the protocol. In PFC+NO group, PAP decreased sig-
nificantly to 26±4 mmHg (p<0.01) after PFC was added,
and further significantly decreased to 20±3 mmHg (p<0.01)
shortly after the beginning of first NO on period. However, as
NO inhalation continued, PAP slowly increased to 22±3
mmHg (p<0.05) at the end of first NO on period. Then, PAP
repeated to rise and fall according to the NO inhalation. PAP
increased abruptly to 34±2 mmHg (p<0.01) at the end of
first NO off period, decreased rapidly back to 24±6 mmHg
(p<0.05) at the end of second NO on period, and finally increased
once more at the end of second NO off period (p=NS). The PAP
values at NO and ON 1 time point in PFC+NO group were
significantly less than those of control group (20±3 mmHg
vs. 28±3 mmHg at NO, p<0.01; 22±3 mmHg vs. 30±4
mmHg at ON1, p<0.01), otherwise there were no intergroup
differences (Fig. 2).
Changes in Gas Exchange
Arterial blood pH (pH), PaO2, and PaCO2 were all signif-
icantly aggravated after lavage in both groups (p<0.01). In
control group, all of above three variables of gas exchange re-
mained in low levels without significant improvements until
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the end of the protocol after LAVAGE (Fig. 3).
In PFC+NO group, pH increased significantly from 7.16
±0.07 to 7.26±0.06 (p<0.05), and PaCO2 decreased signif-
icantly from 59±9 mmHg to 41±6 mmHg (p<0.01) after
PFC was administered. However, both pH and PaCO2 did
not change significantly during and after NO on periods. At
the end of first NO off, however, pH decreased significantly
back to 7.19±0.11 (p<0.01), and PaCO2 increased signifi-
cantly back to 48±7 mmHg (p<0.01). At the end of second
NO off period, there were no such effects. In intergroup com-
parisons, the pH values in PFC+NO group at BASE, NO, and
ON 1 time point were significantly greater than those of con-
trol group (7.78±0.06 vs. 7.65±0.14 at BASE, p<0.05;
7.29±0.07 vs. 7.14±0.13 at NO, p<0.05; 7.30±0.10 vs.
7.14±0.13 at ON1, p<0.05), and the PaCO2 values in PFC+
NO group at NO and ON 1 time point were significantly
less than those of control group (39±7 mmHg vs. 54±15
mmHg at NO, p<0.05; 37±4 mmHg vs. 52±13 mmHg
at ON1, p<0.01) (Fig. 3). After LAVAGE, PaO2 increased
significantly from 45±10 mmHg to 281±99 mmHg (p<
0.01) after PFC was added. Subsequent NO administration
further increased PaO2 significantly to 378±75 mmHg (p<
0.05), and the interruption of NO administration rapidly
decreased PaO2 back to 174±133 mmHg (p<0.01). This
phenomenon was also observed during the next NO ‘on/off’
cycle (increased to 304±119 mmHg, p<0.01; decreased to
162±124 mmHg, p<0.01). In intergroup comparison, the
PaO2 values in PFC+NO group were significantly greater
than those of control group at all time points (p<0.05) (Fig. 3).
Changes in Pulmonary Mechanics
Dynamic compliance decreased significantly and the airway
resistance increased significantly after lavage in both groups
(p<0.01). In control group, both of above two variables of
pulmonary mechanics did not change significantly over a 5-
hr protocol after LAVAGE (Fig. 4).
In PFC+NO group, dynamic compliance significantly
increased from 0.30±0.09 mL/cmH2O/kg to 1.01±0.25
mL/cmH2O/kg (p<0.01) after PFC was administered, and from
0.56±0.19 mL/cmH2O/kg to 0.79±0.22 mL/cmH2O/kg
(p<0.01) during second NO on-but it did not change signifi-
cantly during first NO on. Dynamic compliance significantly
decreased back from 0.91±0.12 mL/cmH2O/kg to 0.56±
0.19 mL/cmH2O/kg (p<0.01) during first NO off, and from
0.79±0.22 mL/cmH2O/kg to 0.60±0.17 mL/cmH2O/kg
(p<0.01) during second NO off. Intergroup comparison demon-
strated that all the values of dynamic compliance in PFC+NO
group, except the value at LAVAGE, were significantly greater
than those of control group (p<0.01) (Fig. 4). After a signif-
icant decrease from 84±48 cmH2O/kg to 49±20 cmH2O/
kg (p<0.05) following an addition of PFC, airway resistance
did not change significantly over time until the end of the
protocol. Intergroup comparison showed that all the values
of airway resistance in PFC+NO group after LAVAGE were
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significantly less than those of control group (p<0.05) (Fig. 4).
Changes in Intrapulmonary Right-to-Left Shunt
After lavage, intrapulmonary right-to-left shunt (shunt)
increased significantly from 9.8±3.8% to 47.0±16.0% in
PFC+NO group (p<0.01), and from 5.2±3.8% to 35.5±
16.0% in control group (p<0.01). In control group, shunt did
not change significantly over a 5-hr protocol after LAVAGE
(Fig. 5).
In PFC+NO group, shunt decreased significantly to 3.9
±2.7% (p<0.01) after PFC was administered. Shortly after
the beginning of first NO on period, shunt decreased further
to 1.1±10.3% (p=NS), but as NO inhalation continued,
shunt slowly increased to 1.9±7.1% (p<0.05) at the end of
first NO on. During First NO off, shunt increased rapidly, but
the increase was not statistically significant. During Second
NO on, shunt decreased back again, but the decrease also was
not significant, either. However, during Second NO off, shunt
increased significantly from 3.6±18.8% to 13.1±5.0% (p<
0.05). Intergroup comparison showed that the shunt values
at PFC, NO, ON 1, and ON 2 in PFC+NO group were sig-
nificantly less than those of control group (3.9±2.7% vs. 29.2
±10.2% at PFC, p<0.01; 1.1±10.3% vs. 29.2±10.3% at
NO, p<0.01; 1.9±7.1% vs. 21.8±7.1% at ON1, p<0.01;
3.6±18.8% vs. 37.8±18.8% at ON2, p<0.01) (Fig. 5).
DISCUSSION
The results of our study showed that PLV with PFC improv-
ed gas exchange, pulmonary mechanics, and ventilation/per-
fusion (V/Q) matching in a lavage-induced acute lung injury
model. Concerning the hemodynamic effects of PFC admin-
istration, PAP reduction was the only one statistically signif-
icant change in the study. The improvement of pulmonary
gas exchange during PLV is attributable to the enhancement
of alveolar recruitment of atelectatic lung regions, especially
in the dependent zone, through the low surface tension and
noncompressible nature of PFC in the alveolus (16, 18, 19).
Moreover, the redistributing effect of the weight of PFC on
the pulmonary blood flow may contribute to the improvement
of gas exchange (20). By this mechanism, pulmonary blood
flow to the relatively well-ventilated zone increases and thus,
V/Q matching is improved. Our findings support this mech-
anism because PFC administration resulted in a significant
decrease in intrapulmonary shunt. PFC administration also
improved dynamic compliance and airway resistance in our
study. These findings are compatible with the previous studies
that demonstrated that PFC increased pulmonary compliance
and reduced airway pressure (3-5, 19, 21-23). The improve-
ments in pulmonary mechanics might have further improved
gas exchange during PLV in our study. Our results confirmed
that there were no significant effects on systemic circulation
by PLV, and these results were also compatible with previous
studies (8, 24). However, regarding pulmonary circulation,
PLV decreased PAP significantly. Uchida et al. and Wilcox
et al. also reported similar findings as ours (22, 24). The reduc-
tion of PAP might have improved pulmonary blood flow and
reduced intrapulmonary right-to-left shunting, but further
study is necessary to confirm this speculation. The mechanism
for the reduction of PAP by PLV is not clear, but may have
been caused by a reduction in hypoxic pulmonary vasoconstric-
tion around the recruited alveoli.
The addition of 10 ppm dose of NO inhalation to PLV fur-
ther improved PaO2, and improved dynamic compliance partly
(only during second NO on period). In terms of hemodynam-
ics, NO inhalation further decreased PAP significantly, and
decreased systemic arterial pressure partly (only during second
NO on period). Because NO inhalation was administered in
an ‘on/off’ manner, we could observe the rebound phenomenon
according to the discontinuation of NO inhalation. In addi-
tion to PaO2and PAP that showed an honest ‘on/off’ response
according to NO inhalation, arterial blood pH, PaCO2, dynam-
ic compliance, airway resistance, and intrapulmonary shunt
showed rebound phenomenon when NO was withdrawn, al-
though their responses to the administration of NO inhala-
tion were absent or incomplete (responded during only one of
two NO on periods). Our results are compatible with the sev-
eral previous studies of combination of PLV and NO inhala-
tion (9, 22, 25-27). All of these studies demonstrated an im-
provement in oxygenation and PAP when short-term (10 to
15 min) inhalation of NO was added to PLV as our study did.
Inhaled NO has shown to increase oxygenation in injured
lung by decreasing pulmonary right-to-left shunt through
its selective vasodilating effect on pulmonary vessels of ven-
tilated areas (10). However, Uchida et al., in their study of
combination of PLV with NO inhalation in the severe oleic
acid lung injury model, observed that NO inhalation did not
improve pulmonary gas exchange during conventional ven-
tilation, while it improved gas exchange during PLV (24).
This observation was supported by several clinical studies, in
which the pulmonary vasodilating effect was not necessarily
accompanied by the improvement of gas exchange in severe
lung injury (13, 28). With regard to this phenomenon, Puy-
basset et al. speculated that pulmonary vasodilation and im-
provement of gas exchange are linked but occur at different
anatomic levels in the lung (28). If pulmonary arteries, alve-
olar territories of which own are poorly ventilated, were dilated
by NO that entered from surrounding well-ventilated alveolar
space, ventilation/perfusion mismatching would be aggravated.
Therefore, recruitment of poorly ventilated alveolar unit is
essential to improve arterial oxygenation caused by NO inhala-
tion. They proved their speculation by demonstrating that
peak end expiratory pressure (PEEP) induced alveolar recruit-
ment potentiated the NO-induced improvements in arterial
oxygenation in ARDS patients. In our current study, NO in-
halation was added after gas exchange was already improvedPartial Liquid Ventilation and Inhaled Nitric Oxide 819
considerably by preceding PFC administration; in other words,
after PLV-induced alveolar recruitment was obtained, and we
confirmed the additional significant improvement in oxygena-
tion by NO inhalation. Moreover, we demonstrated a reduc-
tion of intrapulmonary shunt by adding NO inhalation, al-
though the reduction was not significant. These findings illus-
trate that alveolar recruitment was so sufficient that pulmonary
vasodilating effect of inhaled NO went in a beneficial way
toward the reduction of intrapulmonary shunt, and support
the speculation of Puybasset et al. Furthermore, like above-
mentioned studies (9, 22, 25-27), PAP was significantly de-
creased by adding NO inhalation. This result reflects that the
improvement in oxygenation by adding of NO inhalation may
be attributable to pulmonary vasodilating effect of inhaled NO.
In our current study, the addition of NO inhalation to PLV
affected dynamic compliance. Dynamic compliance signifi-
cantly increased during second NO on period, and decreased dur-
ing first and second NO off periods. These findings were incom-
patible with several studies of combined therapy of PLV and
NO inhalation (22, 25, 29). In their studies, there were no
changes of dynamic compliance by adding NO to PLV. Further
study may be necessary to be able to explain these findings.
According to the study by Houmes et al., there was a sharp
‘on/off’ effect of inhaled NO when added to PLV (26). This
finding suggested a similar kinetic of NO in the PFC-filled
lung compared to conventional gas ventilation. They supposed
that the total amount of NO dissolved in PFC must be low.
Our current results showed a similar rapid ‘on/off’ effect of
inhaled NO on PAP, PaO2, dynamic compliance, and intra-
pulmonary shunt in PLV setting, although we did not set a
conventional gas ventilation control. In the explanation of
the ‘on/off’ effect of inhaled NO in PLV setting, Kaisers and
Rossaint suggested a possibility that inhaled NO is mainly
effective in the air-filled compartment of injured lung (30).
Their speculation is that due to gravitational force, PFC may
preferentially pooled in dependent lung regions, filling and
distending alveoli; whereas in non-dependent, well-ventilated
lung regions, PFC may form thin layers and reduce the sur-
face tension at liquid-gas interfaces, resulting in an improve-
ment in lung mechanics. However, the same gravitational
force may redistribute pulmonary blood flow toward non-de-
pendent, well-ventilated alveoli, which are stabilized by the
surface tension-reducing properties of PFC, therefore, inhaled
NO in air-filled compartment may play a more important
role on improving V/Q matching than NO dissolved in PFC-
filled compartment. Recent study by Uchida et al., in which
the addition of NO inhalation to PLV has shown to significant-
ly increase the pulmonary blood flow to the non-dependent
region and improve pulmonary gas exchange, supports Kaisers
and Rossaint’s speculation (30).
In our current study, we set the control group as a conven-
tional gas ventilation alone group. Therefore, we did not eval-
uate the time-response patterns of PLV and NO inhalation,
respectively. We examined the response of inhaled NO only
in PFC-filled lung. Therefore, it may be complicated to dif-
ferentiate the response of inhaled NO from that of PLV itself.
However, in our pilot study with the same experimental set-
tings (unpublished), three newborn piglets that were given
PFC administration alone were gradually aggravated in terms
of pulmonary hemodynamics, gas exchange, pulmonary me-
chanics, and V/Q matching as time passed, after they showed
a brisk improvement in above outcome measures as soon as
PFC was administered. Moreover, we added NO in an ‘on/off’
manner, not a continuous inhalation, and we could observe
the relevant ‘on/off’ responses in the outcome measures. There-
fore, the problem of the lack of control in our study design
seems to be lessened.
Moreover, we used a fixed dose of PFC (30 mL/kg) and NO
(10 ppm). We adopted these doses from our previous studies,
in which these doses accomplished optimal responses without
significant hemodynamic compromises (32, 33). However,
those studies evaluated the effect of PLV and the effect of NO
inhalation, respectively. Therefore, it may be necessary to eval-
uate the combined effect of PLV and NO inhalation by using
varying doses of PFC and NO, to find the optimal doses of
PFC and NO. According to the study of the combining effect
of PLV and NO inhalation by Houmes et al., in which varying
doses of PFC and NO were used, additional NO inhalation
resulted in a maximal increase in PaO2 at 30±10 ppm NO
at each PFC dose, and maximal effect of additional NO inhala-
tion on PaO2 occurred at 5 mL/kg perflubron dose (26).
In summary, we confirmed that the PLV with PFC improv-
ed gas exchange, and this may be attributable to improved
pulmonary mechanics and V/Q matching. When NO inhala-
tion was combined to PLV, there were further improvements
in gas exchange, and this may be attributable to deceased PAP
and improved V/Q matching. There were no hemodynamic
compromises during the combination therapy. The combina-
tion of these two novel therapies could be investigated for the
infants with severe lung injury.
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